Pancreatic Cancer Trial, Recruiting NCT06084013 Sponsor: OHSU Knight Cancer Institute Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT06084013
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have an open surgical procedure on the pancreas (either removing the head of the pancreas or the tail/body of the pancreas) for any medical reason
  • People who are 18 years of age or older
  • People who are able to understand what the trial involves and what it means for them personally
  • People who have given written consent to participate, either themselves or through a legally authorised representative
  • People who are capable of becoming pregnant must have a negative pregnancy test before joining and must use adequate contraception until at least 14 days after the trial procedure
  • People who will have a surgical drain (a closed suction drain) left in place after their operation
  • People whose surgery does not require repair or reconstruction of the arteries
  • People whose surgery requires only minor repair of the portal vein (a large vein near the pancreas), such as a patch-type repair

Who may not be able to join:

  • People who have previously had a bad reaction to contrast dye, a dye called ICG (indocyanine green), or any of its ingredients
  • People who have previously had surgery to remove part of the pancreas
  • People who have a known diagnosis of liver insufficiency, hepatitis, liver scarring (fibrosis or cirrhosis), or long-term (chronic) pancreatitis
  • People who experience certain serious complications in the days after surgery, including very low blood pressure that does not improve with fluids, an unexpected transfer to intensive care, the need for more than 2 units of blood during surgery or more than 1 unit after surgery, the need for medications to raise blood pressure, or the need for emergency resuscitation
  • People who develop organ failure, a complete stop in urine production, or certain recognised surgical complications — these cases will be reviewed by the lead researcher and the treating surgeon to determine whether the person should be excluded (confirm with trial site)
  • People whose surgery requires reconstruction or repair of the arteries

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrick J Worth, OHSU Knight Cancer Institute

Phone: 503-494-6900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
OHSU Knight Cancer Institute
Registry
ClinicalTrials.gov
Start date
17 May 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of biochemical leak or fistula after pancreatectomy.; Perfusion status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov